Browse our latest media releases, coverage, videos, events and presentations for Atturos...
Scientific paper published in BMC Clinical Proteomics
21st October 2020
Read our latest publication "A robust multiplex immunoaffinity mass spectrometry assay (PromarkerD) for clinical prediction of diabetic kidney disease". This work represents a collaborative effort between the Atturos Team, Proteomics International (Perth) and Sydney Mass Spectrometry.
OCProDx showcased at Enterprise Ireland’s Big Ideas 2018
5th September 2018
Twelve start-ups pitched their new technology solutions to investors at the 10th annual innovation showcase event BIG IDEAS. Atturos were shortlisted and presented OCProDx to an invited audience of Irish research and business communities
Agilent Technologies Lunchtime Workshop at MSACL Annual Conference, Palm Springs, California, U.S.A.
24th January 2018
Atturos development and delivery of MassSpec based multiplexed biomarker assays was presented by Steve Pennington at a lunchtime workshop hosted by Agilent at the Mass Spectrometry Applications to the Clinical Lab 10th Annual Conference Palm Springs, California, U.S.A.
HUPO’s Proteome Project releases the 10-year High‑Stringency Blueprint of the Human Proteome
16th October 2020
Atturos founder, Steve Pennington, and Senior Scientist, James Waddington, played a key role in publication of the Human Proteome Project’s blueprint of the Human Proteome 'A high-stringency blueprint of the human proteome'.
Atturos begins collaboration with Merck KGaA, Darmstadt, Germany
23rd April 2018
Atturos is pleased to announce it has begun a significant collaboration with Merck KGaA. “The projects sees Atturos developing important LC-MS workflows for Merck KGaA and marks what both companies hope will be a series of ongoing collaborative projects” notes Dave Corr, CEO Atturos Ltd.
Founder and Chief Scientific Officer Prof. Stephen Pennington presents Atturos work at the Clinical and Pharmaceutical Solutions through Analysis Symposium in Philadelphia, Pennsylvania, U.S.A on the 28th of October 2019.
Proteomics International and Atturos Partner to Target Diagnostics in Europe
19th September 2018
Proteomics International and Irish clinical diagnostics company Atturos have signed a Memorandum of Understanding that will see the companies join forces to develop novel diagnostic tests for the European region.
Atturos Host Clinical and Technical Brainstorming Sessions with Key Opinion Leaders
16th May 2016
Last Friday May 13th Atturos hosted a Clinical and Technical Brainstorming session in NovaUCD as part of our market analysis to obtain and evaluate customer and end user attitudes towards the OCProDx test...